NCT05512351 2022-09-27Sintilimab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for ctDNAlevel- Relapse and Clinical-relapse OligodendrogliomaHenan Provincial People's HospitalPhase 2 Recruiting80 enrolled